Serum copeptin and cortisol do not accurately predict sickle cell anaemia vaso-occlusive crisis as C-reactive protein

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Akinlade, Kehinde Sola ^a   Atere, Adedeji David ^a   Olaniyi, John Ayodele ^b   Rahamon, Sheu Kadiri ^a   Adewale, Christiana Odunayo ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COPEPTIN; HYDROCORTISONE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; SICKLE CELL ANEMIA; SICKLE CELL CRISIS;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; AREA UNDER CURVE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; GLYCOPEPTIDES; HUMANS; HYDROCORTISONE; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; YOUNG ADULT;

EID: 84892428792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077913     Document Type: Article

References (45)

1. Porter LS, Gil KM, Carson JW, Anthony KK, Ready J (2000) The role of stress and mood in sickle cell disease pain: an analysis of daily diary data. J Health Psychol 5(1): 53-63.
2. Nadel C, Portadin G (1977) Sickle cell crises: Psychological factors associated with onset. New York State Journal of Medicine 77(7): 1075-1078.
3. McEwen B (2000) Allostasis and allostatic load: Implication for neuropsycho-pharmacology. Neuropsychopharmacology 22: 108-124.
4. Marik PE, Zaloga GP (2002) Adrenal insufficiency in the critically ill. A new look at an old problem. Chest 122: 1784-1796.
5. Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, et al. (2000) A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 283: 1038-1045.
6. Sam S, Corbridge TC, Mokhlesi B, Comelias AP, Molitch ME (2004) Cortisol levels and mortality in severe sepsis. Clin Endocrinol 60: 29-35.
7. Osifo BO, Lukambi FA, Adekile A (1988) Plasma cortisol in sickle cell disease. Acta Haematol 79: 44-45.
8. el-Hazmi MA, Bahakim HM, al-Fawaz I (1992) Endocrine functions in sickle cell anaemia patients. J Trop Pediatr 38(6): 307-313.
9. Joels M, Baram TZ (2009) The neuro-symphony of stress. Nat Rev Neurosci 10(6): 459-466.
10. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52: 112-119.
11. Katan M, Christ-Crain M (2010) The stress hormone copeptin: a new prognostic biomarker in acute illness. Eur J Med Services 140: 13101.
12. Struck J, Morgenthaler NG, Bergmann A (2005) Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26(12): 2500-2504.
13. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, et al. (2007) Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28(2): 219-226.
14. Latendresse G, Ruiz RJ (2008) Bioassay research methodology: measuring CRH in pregnancy. Biol Res Nurs 10(1): 54-62.
15. Stolz D, Christ-Crain M, Morgenthaler NG, Leuppi J, Miedinger D, et al.(2007) Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 131(4): 1058-1067.
16. Muller B, Morgenthaler N, Stolz D, Schuetz P, Muller C, et al. (2007) Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 37(2): 145-152.
17. Urwyler SA, Schuetz P, Fluri F, Morgenthaler NG, Zweifel C, et al. (2010) Prognostic value of copeptin: one-year outcome in patients with acute stroke. Stroke 41(7): 1564-1567.
18. Katan M, Nigro N, Fluri F, Schuetz P, Morgenthaler NG, et al. (2011). Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology 76(6): 563-566.
19. Dong XQ, Huang M, Yang SB, Yu WH, Zhang ZY (2011) Copeptin is associated with mortality in patients with traumatic brain injury. J Trauma 71(5): 1194-1198.
20. Katan M, Morgenthaler N, Widmer I, Puder JJ, König C, et al. (2008) Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 29(3): 341-346.
21. Nickel CH, Bingisser R, Morgenthaler NG (2012) The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Medicine 10: 7.
22. Christou NV, Tellado-Rodriguez J, Chartrand L, Giannas B, Kapadia B, et al. (1989) Estimating mortality risk in preoperative patients using immunologic, nutritional, and acute-phase response variables. Ann Surg 210: 69-77.
23. Deans C, Wigmore SJ (2005) Systemic inflammation, cachexia, and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8: 265-269.
24. Kao PC, Shiesh SC, Wu TJ (2006) Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci 36: 163-169.
25. Hedo CC, Aken'ova YA, Okpala IE, Durojaiye AO, Salimonu LS (1993) Acute phase reactants and severity of homozygous sickle cell disease. Journal of Internal Medicine 233: 467-470.
26. Pearson T (2003) Markers of inflammation and cardiovascular disease. AHA/CDC Scientific Statement. Circulation 107: 499.
27. Zacho J, Hansen AT, Jensen JS, Grande P, Sillesen H, et al. (2008) Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease. N Engl J of Med 359: 1897-1908.
28. Schultz DR, Arnold PI (1990) Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, glycoprotein and fibrinogen. Seminars in Arthritis and Rheumatism 20: 129-147.
29. Kushner I (1991) C-reactive protein in rheumatology. Arthritis Rheum 34: 1065-1068.
30. Dixon JS (1984) C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheum 13: 39-44.
31. Stuart J, Stone PC, Akinola NO, Gallimore JR, Pepys MB (1994) Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease. Clin Pathol 47: 166-169.
32. Arnon B, Aviva P, Monir M, Imad T, Khalid K, et al. (2005) High-sensitive Creactive protein (hs-CRP) level in patients with sickle cell anaemia. Haema 8(3): 462-464.
33. Mohammed FA, Mahdi N, Sater MA, Al-Ola K, Almawi WY (2010) The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease. Blood Cells Mol Dis 45(4): 293-296.
34. Omoti CE (2005) Haematological values in sickle cell anaemia in steady state and during vaso-occlusive crises in Benin City, Nigeria. Ann Afr Med 4(2): 62-67.
35. Soyannwo OA, Amanor-Boadu SD, Sanya AO, Gureje O (2000) Pain assessment in Nigerians-Visual Analogue Scale and Verbal Rating Scale compared. West Afr J Med 19: 242-245.
36. Mold C, Rodriguez W, Rodic-Polic B (2002) C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R. J Immunol 169: 7019-7025.
37. Krishnan S, Setty Y, Betal SG, Vijender V, Rao K, et al. (2010) Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. Br J Haematol 148(5): 797-804.
38. Makis AC, Hatzimichael EC, Stebbing J, Bourantas KL (2006) C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell disease. Archives of Internal Medicine 166: 366-368.
39. Akohoue SA, Shankar S, Milne GL, Morrow J, Chen KY, et al. (2007) Energy expenditure, inflammation, and oxidative stress in steady state adolescents with sickle cell anemia. Pediatr Res 61: 233-238.
40. Rosenbloom BE (1980) Pituitary-adrenal axis function in sickle cell anemia and its relationship to leukocyte alkaline phosphatase. Am J Hematol 9: 373-379.
41. Saad ST, Saad MJ (1992) Normal cortisol secretion in sickle cell anaemia. Trop Geogr Med 44: 86-88.
42. Abbiyesuku FM, Osotimehin BO (1999) Anterior pituitary gland assessment in sickle cell anaemia patients with delayed menarche. Afr J Med Med Sci 28: 65-69.
43. Jochberger S, Morgenthaler NG, Mayr VD, Luckner G, Wenzel V, et al. (2006) Copeptin and arginine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab 91: 4381-4386.
44. Limper M, Goeijenbier M, Wagenaar JF, Gasem MH, Isbandrio B, et al. (2010) Copeptin as a predictor of disease severity and survival in leptospirosis. J Infect 6: 92-94.
45. van Wolfswinkel ME, Hesselink DA, Hoorn EJ, de Rijke YB, Koelewijn R, et al.(2012) Copeptin does not accurately predict disease severity in imported malaria. Malar J 11: 6.